scorecardresearch
Friday, August 29, 2025
TopicCovaxin

Topic: Covaxin

Covaxin effectively neutralises both Delta & Alpha variants of Covid, US NIH studies find

Interim results from the phase 3 trial indicate that Covaxin has 78% efficacy against symptomatic disease & 100% efficacy against severe Covid, including hospitalisation, NIH said.

Young children may not need Covid vaccines: ICMR chief tells MPs’ panel amid 3rd wave fear

Dr Balram Bhargava told the panel that ICMR is entitled to 5% royalty on sale price of Covaxin & said it could be possible to break chain of infection if 30% of people get even 1 dose.

Covaxin phase 3 trial data showing ‘77.8% efficacy’ reviewed by expert panel. Over to DCGI

Subject Expert Committee, which advises DCGI on approvals for new drugs & vaccines. has not yet discussed changing the status of Covaxin from emergency use to full licensure.

CDL, Kasauli — the Himachal lab which makes sure that every Covid vaccine you get is safe

Central Drugs Laboratory, Kasauli, is only lab authorised to test safety & efficacy of vaccines in India, including those for Covid. It's also only lab authorised by WHO to test vaccines exported from India.

Final verdict on Covaxin efficacy could come soon as Bharat Biotech submits phase 3 trial data

Bharat Biotech submitted phase 3 trial data of Covaxin to the Drug Controller General of India. The data is crucial to ascertaining the efficacy of a vaccine.

Why Aatish Taseer predicts ‘inevitability’ to confrontation between Bollywood & Modi

A selection of the best news reports, analysis and opinions published by ThePrint this week.

WHO accepts Bharat Biotech’s expression of interest for Covaxin

A pre-submission meeting with WHO will take June 23 during which the vaccine maker will have an opportunity to submit a summary on the overall quality of the jab.

India’s ZyCoV-D set to become world’s first DNA Covid vaccine as govt approval likely soon

Gujarat-based Zydus Cadila has told Modi govt that it could apply for emergency use authorisation for ZyCoV-D vaccine in the next 10-12 days.

Sambit Patra attacks Congress after party leader claims calf serum used in Covaxin

The BJP leader says Congress is trying to create doubts about the indigenous vaccine produced by Bharat Biotech when the country is fighting the second wave of the pandemic.

Social media ‘twisted’ facts on Covaxin containing newborn calf serum, says health ministry

Newborn calf serum is used only for the preparation & growth of vero cells. Serum from bovine and other animal are enrichment ingredient used globally, the ministry added.

On Camera

With Param Sundari, the North-South divide is back

Bollywood has clearly not learned anything from its past mistakes. The habit of stereotyping South Indians claims its latest victim in Param Sundari — the Malayalis.

Easy loans, uneasy ‘debt traps’. Women harassed by private lenders ask ‘who will restore lost dignity?’

A public meeting, where the women voiced their protest, took place this month in Delhi, grounded on the findings of an AIDWA survey, covering 9,000 women borrowers.

Post-Sindoor, joint doctrine tasks Special Forces with fighting info warfare & countering propaganda

Joint Doctrine for Special Forces Operations, released Wednesday, also outlines plans for the future expansion of AFSOD and the creation of Joint Service Training Institutes.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.